Skip to main content

Ke Cheng, Ph.D.Congratulations to Ke Cheng, Ph.D., Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine, Department of Molecular Biomedical Sciences, NC State University and UNC/NCSU Joint Department of Biomedical Engineering; Adjunct Professor, UNC Eshelman School of Pharmacy, in collaboration with UNC-Chapel Hill and Duke University colleagues, for leading the development of the inhalable COVID-19 vaccine prototype from proof-of-concept to animal studies.




During the development, Dr. Cheng and the group of researchers also published two papers, one in the journal Extracellular Vesicle, titled “Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung”, and the other in the journal Nature Biomedical Engineering, titled “Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine”.  Read More